ProFunds Pharmaceuticals UltraSector Fund Investor Class (PHPIX)
| Fund Assets | 2.25M |
| Expense Ratio | 1.78% |
| Min. Investment | $15,000 |
| Turnover | 207.00% |
| Dividend (ttm) | 0.26 |
| Dividend Yield | 1.14% |
| Dividend Growth | 120.59% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 31, 2024 |
| Previous Close | 23.67 |
| YTD Return | -6.77% |
| 1-Year Return | -4.54% |
| 5-Year Return | 15.03% |
| 52-Week Low | 19.17 |
| 52-Week High | 29.81 |
| Beta (5Y) | n/a |
| Holdings | 52 |
| Inception Date | Jun 28, 2000 |
About PHPIX
Pharmaceuticals UltraSector ProFund Investor Class is a mutual fund designed to provide **leveraged exposure to the U.S. pharmaceuticals sector**. The fund seeks to deliver daily investment results—before fees and expenses—that correspond to **150% (1.5x) of the daily performance of the S&P Pharmaceuticals Select Industry Index**. By using derivatives and other financial instruments, it aims to magnify the short-term movements of this benchmark, making it a tool for investors seeking amplified returns linked to the performance of pharmaceutical companies. The fund primarily invests in equities of domestic pharmaceutical firms and may also use options, swaps, and other strategies to achieve its targeted leverage. Pharmaceuticals UltraSector ProFund Investor Class is notable for its **sector concentration**, focusing exclusively on pharmaceutical businesses, and does not diversify across other industries. Established in June 2000 and managed by ProFund Advisors, it plays a specialized role in the market for participants who wish to tactically express a strong view—positive or negative—on the pharmaceuticals industry within the U.S. equity landscape. The fund's leveraged objective is reset daily, so its longer-term returns can deviate significantly from 1.5x the underlying index due to compounding and volatility effects.
Performance
PHPIX had a total return of -4.54% in the past year, including dividends. Since the fund's inception, the average annual return has been 1.92%.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
| Symbol | Share Class | Expense Ratio |
|---|---|---|
| PHPSX | Service Class | 2.78% |
Top 10 Holdings
33.79% of assets| Name | Symbol | Weight |
|---|---|---|
| SOCIETE' GENERALE 4.23 , 5/01/2025 | n/a | 5.90% |
| HSBC SECURITIES (USA), INC. 4.28 , 5/01/2025 | n/a | 5.61% |
| Corcept Therapeutics Incorporated | CORT | 3.52% |
| Eli Lilly and Company | LLY | 2.95% |
| Tarsus Pharmaceuticals, Inc. | TARS | 2.83% |
| Royalty Pharma plc | RPRX | 2.69% |
| Zoetis Inc. | ZTS | 2.61% |
| Johnson & Johnson | JNJ | 2.59% |
| Pfizer Inc. | PFE | 2.56% |
| Axsome Therapeutics, Inc. | AXSM | 2.53% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 31, 2024 | $0.26164 | Jan 2, 2025 |
| Dec 28, 2023 | $0.11861 | Dec 29, 2023 |
| Dec 21, 2020 | $0.10458 | Dec 22, 2020 |
| Dec 27, 2018 | $0.79672 | Dec 27, 2018 |
| Dec 20, 2017 | $1.09567 | Dec 20, 2017 |
| Dec 21, 2015 | $0.02003 | Dec 21, 2015 |